LeSoleil-T

N/A

Report date: 2024/11/14 10:11:55
NME

Base Information

Drug NameLeSoleil-T
Drug Alias NameLeSoleil-T
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus spike glycoprotein modulatorsSARS-CoV-2-3C-like-proteinase inhibitorsTransmembrane protease serine 2 inhibitors
TargetsCoronavirus spike glycoproteinSARS-CoV-2-3C-like-proteinaseTransmembrane protease serine 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuntrap Life Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuntrap Life Technologies Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A